|Product name||Recombinant Human CTLA-4 Protein|
|Description||Recombinant Human CTLA-4 Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Ala37-Phe162) of human CTLA-4 (Accession #NP_005205.2) fused with a 6×His tag at the C-terminus.|
|Bio-Activity||Measured by its binding ability in a functional ELISA. Immobilized lpilimumab at 1 μg/mL (100 μL/well) can bind Recombinant Human CTLA-4 with a linear range of 6-18 ng/mL.|
|Purity||> 90% by SDS-PAGE.|
|Endotoxin||< 1.0 EU/μg of the protein by LAL method.|
|Formulation||Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4.Contact us for customized product form or formulation.|
|Synonym||ALPS5; CD; CD152; CELIAC3; CTLA-4; GRD4; GSE; IDDM12|
|Expressed Host||HEK293 cells|
|Storage||Store the lyophilized protein at -20°C to -80 °C for long term.|
After reconstitution, the protein solution is stable at -20 °C for 3 months, at 2-8 °C for up to 1 week.
|Reconstitution||Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water.|
* For research use only. Not for therapeutic or diagnostic purposes.
Submit your question about RP01044 below and we will get back to you within one business day.
Alternatively, call us at 888.754.5670.